Comments

Pharming Stock Price, Quotes and Forecasts

Q: What sector and industry does Pharming (PHAR) operate in?

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PHARNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.09

At close: Apr 10 EDT

$8.08

-0.01000-0.12%

Pre-Market: 7:25 PM EDT

Pharming (PHAR) Forecast

News Earnings Pharming (PHAR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Pharming Stock Price, Quotes and Forecasts | NASDAQ:PHAR | Benzinga

Explore Pharming stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHAR.

Open	-
Close	-
Volume / Avg.	0 / 6.67K
Day Range	- - -
52 Wk Range	6.65 - 11.30
Market Cap	$552.62M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

Recent News

G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Pharming's Phase 3 trial results for leniolisib in children with APDS demonstrate efficacy and safety, supporting future regulatory filings in 2025.

Vandana Singh

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Dec 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 6.67K
Day Range	- - -
52 Wk Range	6.65 - 11.30
Market Cap	$552.62M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1

About Pharming Group N.V.

Sector

Health Care

Industry

Biotechnology

Pharming Group is a biopharmaceutical company. Its commercial products are RUCONEST, approved for th...

Got Questions? Ask

How is PHAR's price-to-book ratio?

How is the earnings season affecting PHAR?

What is PHAR's all-time high price?

What is PHAR's dividend yield?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pharming (PHAR) stock?

You can purchase shares of Pharming (NASDAQ:PHAR) through any online brokerage.

View our list of the best stock brokerages

Who are Pharming (PHAR) competitors?

Other companies in Pharming’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE) and Valneva (NASDAQ:VALN).

What is the forecast, or price target, for Pharming (PHAR) stock?

Pharming has a consensus price target of $30.00.

What is the current price for Pharming (PHAR)?

The stock price for Pharming (NASDAQ: PHAR) is $8.08 last updated April 10, 2025 at 7:25 PM EDT.

Does Pharming (PHAR) pay a dividend?

There are no upcoming dividends for Pharming.

When is Pharming (NASDAQ:PHAR) reporting earnings?

Pharming’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Pharming (PHAR) going to split?

There is no upcoming split for Pharming.

What sector and industry does Pharming (PHAR) operate in?

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.